Key points are not available for this paper at this time.
This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.
Dagan et al. (Wed,) studied this question.